Hutch News
Results per Page:
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients
How new drugs become available to more patients
Filling in the unknowns on the balance between risk and benefit
Fred Hutch Statement Regarding the FDA Action on CTL019 Immunotherapy
Fred Hutch expert comments on FDA approval of new Novartis immunotherapy drug CTL019 — August 30, 2017
Our smoking cessation expert answers questions on e-cigarettes and the FDA's push to limit nicotine
Smoking cessation expert Dr. Jonathan Bricker weighs in on new studies and a federal effort to regulate an ‘astonishingly addictive’ drug
Fred Hutch Statement Regarding FDA Briefing About CAR T-cell Therapy
Fred Hutch immunotherapy expert comments on FDA staff review of CAR T-cell therapy
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
How to eat: 6 simple tips from a nutrition researcher
Dr. Marian Neuhouser, who helped create the new U.S. Dietary Guidelines, shares how she eats – and how you should, too
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’
Health risks continue after combined menopausal hormone therapy stops
Women's Health Initiative follow-up study confirms that health risks of long-term estrogen plus progestin hormone therapy outweigh benefits for postmenopausal women
Fred Hutchinson Cancer Research Center Study Shows Retinoids Kill Childhood Brain Tumor Cells
Previous Food and Drug Administration approval for use of retinoids to treat another form of childhood cancer, will mean clinical trials in pediatric medulloblastoma patients to begin with minimal delay
FDA Clears For Market New Diagnostic Test For Lupus
Test will help bridge detection gap for systemic lupus erythematosus, or SLE
FDA Clears For Market New Diagnostic Test For Lupus
Test will help bridge detection gap for systemic lupus erythematosus, or SLE
Fred Hutchinson Cancer Research Center's Puget Sound Oncology Consortium to Participate in Nationwide Study to Evaluate the Benefit of Herceptin Therapy
Center Seeks Women with Early Stage Breast Cancer to Participate in the Study
Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia
Fred Hutchinson Cancer Research Center Researcher Presents Updated Study Results at the American Society of Clinical Oncology Meeting in New Orleans